Impact of Blood Storage Duration on Physiologic Measures (RECAP)

February 1, 2017 updated by: Duke University

Impact of Blood Storage Duration on Physiologic Measures: RECESS Ancillary Physiologic Study (RECAP)

This study is an ancillary (add-on) study to the clinical trial entitled Red Cell Storage Duration Study (RECESS), which has clinicaltrials.gov identifier NCT00991341. The RECESS study randomizes cardiac surgery patients to receive either red blood cell units stored for no more than 10 days, or red blood cell units stored for at least 21 days, if they need any red blood cell transfusions during their hospital stay for the surgery.

This ancillary study is entitled Impact of Blood Storage Duration on Physiologic Measures: RECESS Ancillary Physiologic Study (RECAP). The hypothesis of the RECAP study is that there will be differences between the two randomized treatment groups in how much the following measurements change, from shortly before a red blood cell transfusion to shortly after a red blood cell transfusion, and from before surgery to 24 hours after surgery:

  • Oxygen saturation in the hand
  • Oxygen saturation in the brain
  • Blood flow in the small blood vessels under the tongue.

The RECAP study will also investigate whether changes in the measurements listed above are associated with clinical outcomes, including

  • The Multi-Organ Dysfunction Score
  • Death from any cause
  • Major cardiac events
  • Major pulmonary events

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Anticipated)

390

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital
      • Boston, Massachusetts, United States, 02115
        • Brigham and Womens Hospital
    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota
    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Cardiac surgery patients enrolled in the RECESS study (NCT00991341) at selected hospitals

Description

Inclusion Criteria:

  • Eligible and randomized in the RECESS study (NCT00991341)
  • At least 18 years old
  • Willing to comply with protocol and provide written informed consent for both RECESS and RECAP
  • Scheduled to undergo coronary artery bypass (CABG), valve, or combined CABG plus valve surgery

Exclusion Criteria:

  • Prior randomization into the RECESS or RECAP studies
  • Undergoing off-pump cardiac surgery
  • Undergoing a significant concomitant surgical procedure
  • Known sickle cell disease
  • Participation in a clinical trial (except observational studies or RECESS) within the previous 30 days
  • Received any investigational product within prior 30 days
  • Not able to be randomized in RECESS

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Shorter-storage red blood cell units
Red blood cell units stored <= 10 days
Longer-storage red blood cell units
Red blood cell units stored >= 21 days

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in thenar oxygenation saturation
Time Frame: From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in downslope of thenar oxygen saturation
Time Frame: From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Change in upslope of thenar oxygen saturation
Time Frame: From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Change in cerebral oxygenation
Time Frame: From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Change in microvascular mean flow index
Time Frame: From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Change in percent perfused vessels
Time Frame: From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Change in capillary density index
Time Frame: From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Change in thenar oxygen saturation
Time Frame: From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Change in downslope of thenar oxygen saturation
Time Frame: From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Change in upslope of thenar oxygen saturation
Time Frame: From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Change in cerebral oxygenation
Time Frame: From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Change in microvascular mean flow index
Time Frame: From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Change in percent perfused vessels
Time Frame: From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Change in capillary density index
Time Frame: From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Change in multi-organ dysfunction score
Time Frame: From pre-surgery baseline to post-operative Day 7, hospital discharge, or death, whichever occurs first
From pre-surgery baseline to post-operative Day 7, hospital discharge, or death, whichever occurs first
All-cause mortality
Time Frame: Through post-operative Day 28
Through post-operative Day 28
Composite of major cardiac events
Time Frame: Through post-operative Day 7, hospital discharge, or death, whichever occurs first
Through post-operative Day 7, hospital discharge, or death, whichever occurs first
Composite of major pulmonary events
Time Frame: Through post-operative Day 7, hospital discharge, or death, whichever occurs first
Through post-operative Day 7, hospital discharge, or death, whichever occurs first

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Elliott Bennett-Guerrero, MD, Duke University
  • Principal Investigator: Christopher Stowell, MD, PHD, Massachusetts General Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

January 1, 2014

Study Completion (Actual)

January 1, 2014

Study Registration Dates

First Submitted

January 9, 2011

First Submitted That Met QC Criteria

January 9, 2011

First Posted (Estimate)

January 11, 2011

Study Record Updates

Last Update Posted (Estimate)

February 2, 2017

Last Update Submitted That Met QC Criteria

February 1, 2017

Last Verified

July 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00021198
  • R01HL101382 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Surgery

Subscribe